MXPA02008398A
(en )
2003-09-05
High early-strength cementitious composition.
PL359064A1
(en )
2004-08-23
Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
SG76000A1
(en )
2000-10-24
Chemical amplification type positive resist composition
MXPA02004048A
(en )
2003-08-20
Cement composition.
HUP0301745A3
(en )
2010-03-29
Cyclopentanoindoles, compositions containing such compounds and their use
GB2373866B
(en )
2003-03-26
Chemical amplifying type positive resist composition
AU2495400A
(en )
2000-08-01
Surfactant compositions containing alkoxylated amines
ZA200108083B
(en )
2002-11-27
Compositions for improving fertility.
AU2002360759A1
(en )
2003-07-09
Polyether carbamate compounds, compositions containing such compounds, and methods related thereto
HK1050217A1
(en )
2003-06-13
Clearance of neoplastic cells from mixed cellular compositions using viruses
ZA200302929B
(en )
2004-04-14
Compositions comprising cyclohexamantane.
AU4274001A
(en )
2001-10-08
Chemical amplification type positive resist composition
IL152390A0
(en )
2003-05-29
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
AU2001296907A1
(en )
2002-04-08
New cellular architecture
ATE377068T1
(en )
2007-11-15
SURFACTANT COMPOSITIONS CONTAINING IMPROVEMENT AGENTS
AU2001275085A1
(en )
2001-12-11
Methods, compounds and compositions for treating gout
GB2356258B
(en )
2001-12-19
Chemical amplification type resist composition
SG105527A1
(en )
2004-08-27
Chemical amplifying type positive resist composition
GB2373867B
(en )
2003-03-26
Chemical amplification type positive resist composition
GB0000187D0
(en )
2000-03-01
Chemical compositions II
ZA200208733B
(en )
2003-10-29
Clearance of neoplastic cells from mixed cellular compositions using viruses.
GB2370367B
(en )
2003-02-19
Chemical amplifying type positive resist composition
GB0000186D0
(en )
2000-03-01
Chemical compositions I
GB2372334B
(en )
2003-04-09
Chemical amplifying type positive resist compositions
TWI319005B
(en )
2010-01-01
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions